Abstract

To study the association between HbA1c and sepsis in adults with type 1 diabetes, and to explore the relationship between HbA1c and mortality among individuals who developed sepsis. We included 33,549 adult individuals with type 1 diabetes recorded in the Swedish National Diabetes Register between January, 2005 and December, 2015. We used multivariable Cox regression and restricted cubic spline analyses to study the relationship between HbA1c values and sepsis occurrence and association between HbA1c and mortality among those with sepsis. A total of 713 (2.1%) individuals developed sepsis during the study period. Compared to the HbA1c reference interval of 48-52 mmol/mol (6.5-6.9%), the adjusted hazard ratio for sepsis was 2.50 (95% CI 1.18-5.29) for HbA1c <43 mmol/mol, 1.88 (95% CI 0.96-3.67) for HbA1c 43-47 mmol/mol, 1.78 (95% CI 1.09-2.89) for HbA1c 53-62 mmol/mol, 1.86 (95% CI 1.14-3.03) for HbA1c 63-72 mmol/mol, 3.15 (95% CI 1.91-5.19) for HbA1c 73-82 mmol/mol, and 4.26 (95% CI 2.53-7.16) for HbA1c >82 mmol/mol. On multivariable restricted cubic spline analysis we found a J-shaped association between HbA1c and sepsis risk, with the lowest risk observed around a HbA1c of 53 mmol/mol. We found no association between HbA1c and mortality among those individuals who developed sepsis. In our nationwide observational study of adult individuals with type 1 diabetes we found a J-shaped relationship between HbA1c and risk of sepsis, with lowest risk at HbA1c levels around 53 mmol/mol (7.0%). HbA1c was not associated with mortality in individuals affected by sepsis. This article is protected by copyright. All rights reserved.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call